Lumasiran for Patients With Primary Hyperoxaluria Type 1 and Impaired Kidney Function: 12-Month Analysis of the Phase 3 ILLUMINATE-C Trial

被引：0

作者：

Frishberg, Yaacov ^{[1
]}

Michael, Mini ^{[2
,3
]}

Groothoff, Jaap ^{[4
,5
]}

Shasha-Lavsky, Hadas ^{[6
]}

Lieske, John C. ^{[7
]}

Simkova, Eva ^{[8
]}

Sellier-Leclerc, Anne-Laure A. ^{[9
]}

Devresse, Arnaud ^{[10
]}

Egziabher, Fitsum Guebre ^{[11
]}

Bakkaloglu, Sevcan A. ^{[12
]}

Mourani, Chebl ^{[17
]}

Saqan, Rola ^{[13
]}

Singer, Richard F. ^{[14
]}

Willey, Richard G. ^{[15
]}

Gansner, John M. ^{[15
]}

Magen, Daniella ^{[16
]}

机构：

[1] Shaare Zedek Med Ctr, Jerusalem, Israel

[2] Texas Childrens Hosp, Houston, TX USA

[3] Baylor Coll Med, Houston, TX USA

[4] Emmas Childrens Hosp, Amsterdam, Netherlands

[5] Univ Amsterdam, Dept Pediat Nephrol, Amsterdam, Netherlands

[6] Galilee Med Ctr, Nahariyya, Israel

[7] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA

[8] Al Jalila Childrens Specialty Hosp, Dubai, U Arab Emirates

[9] Hop Femme Mere Enfant, Bron, France

[10] Clin Univ St Luc, Brussels, Belgium

[11] Hop Edouard Herriot, Lyon, France

[12] Gazi Univ, Ankara, Turkiye

[13] Jordan Univ Sci & Technol, Irbid, Jordan

[14] Canberra Hlth Serv, Garran, ACT, Australia

[15] Alnylam Pharmaceut Inc, Cambridge, MA USA

[16] Rambam Hlth Care Campus, Haifa, Israel

[17] Hotel Dieu France, Beirut, Lebanon

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

FR-PO335

引用

页码：416 / 416

页数：1